Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals

H Bickel1, E Mosch, E Seigerschmidt

  • 1Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Klinikum rechts der Isar, Deutschland. h.bickel@lrz.tum.de

Insights

Mild cognitive impairment (MCI) affects over a third of elderly hospital patients. These cognitive deficits often persist, highlighting hospitals as key sites for early dementia detection.

Area of Science:

  • Gerontology
  • Neurology
  • Public Health

Background:

  • Mild cognitive impairment (MCI) is a growing concern in aging populations.
  • Early detection of cognitive decline is crucial for timely intervention and management.
  • General hospitals serve a large elderly demographic, potentially including individuals with undiagnosed MCI.

Purpose of the Study:

  • To determine the prevalence of MCI in elderly patients admitted to general hospitals.
  • To assess the persistence of cognitive deficits in these patients post-discharge.
  • To evaluate the potential of general hospitals for early identification of dementia.

Main Methods:

  • A cohort of 794 non-demented patients aged 65-85 years was recruited from general hospitals.
  • Cognitive function was assessed during hospitalization and at a follow-up approximately 3.5 months after discharge.
  • Prevalence rates and positive predictive values for cognitive impairment were calculated.

Main Results:

  • The prevalence of MCI among elderly general hospital patients was found to be 36.1%.
  • The positive predictive value for cognitive impairment at 3.5 months post-discharge was 61.0%.
  • Multiple-domain MCI showed particular stability, with a positive predictive value of 82.9%.

Conclusions:

  • Elderly patients in general hospitals represent a high-risk population for MCI.
  • General hospitals provide a valuable setting for the early detection of MCI and potential incipient dementia.
  • Cognitive deficits, especially in multiple domains, tend to be persistent, underscoring the need for follow-up.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...